New flu vaccine protects mice against multiple strains
Meeting Announcement
Updates every hour. Last Updated: 29-Oct-2026 00:16 ET (29-Oct-2026 04:16 GMT/UTC)
A new, nanoparticle vaccine could one day grant patients immunity to the flu with fewer trips to the doctor and without health officials correctly guessing which flu strains will become dominant each year.
A research team at Kumamoto University has developed a new blood-based approach that could help detect breast cancer recurrence by looking beyond conventional genetic mutations and examining how DNA is packaged inside cells.
Foliar application of ZnO nanoparticles at booting outperforms ZnSO₄ in direct-seeded rice, simultaneously raising polished grain Zn, spikelets per panicle and 1000-grain weight while lowering amylose and chalkiness. Transcriptomics links these gains to upregulated α-amylase genes (OsAmy1C, OsRAmy1A) and suppressed cytokinin-degrading OsCKX2, revealing a nano-specific transcriptional rewiring that breaks the yield–quality trade-off.
Chikungunya virus (CHIKV) infection lacks widely available antiviral therapies. In this study, researchers established a CHIKV replicon particle-based high-content screening platform and identified three antiviral compounds, MDL-12330A, bazedoxifene acetate, and anidulafungin. These compounds displayed distinct antiviral profiles by targeting different stages of the CHIKV life cycle, providing new insights into host–virus interactions and potential antiviral strategies.
Technology Developed to Control Microbial Communities in Activated Sludge at Nitrogen Removal Treatment Plants